Medicus Pharma [MDPLD] vs Eli Lilly and [LLY] Detailed Stock Comparison

Medicus Pharma Ltd.

NASDAQ
Loading...

Eli Lilly and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Medicus Pharma Ltd. wins in 2 metrics, Eli Lilly and Company wins in 9 metrics, with 1 ties. Eli Lilly and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medicus Pharma Ltd. Eli Lilly and Company Better
P/E Ratio (TTM) -1.47 40.09 Eli Lilly and Company
Price-to-Book Ratio 3.90 31.01 Medicus Pharma Ltd.
Debt-to-Equity Ratio 0.10 165.31 Medicus Pharma Ltd.
PEG Ratio N/A 0.79 N/A
EV/EBITDA 0.00 26.61 Tie
Profit Margin (TTM) 0.00% 31.67% Eli Lilly and Company
Operating Margin (TTM) 0.00% 44.90% Eli Lilly and Company
EBITDA Margin (TTM) N/A 44.90% N/A
Return on Equity -841.91% 101.16% Eli Lilly and Company
Return on Assets (TTM) -358.37% 19.42% Eli Lilly and Company
Free Cash Flow (TTM) $-4.16M $5.96B Eli Lilly and Company
Dividend Yield N/A 0.60% N/A
1-Year Return N/A 38.28% N/A
Price-to-Sales Ratio (TTM) N/A 12.63 N/A
Enterprise Value $0 $843.37B Eli Lilly and Company
EV/Revenue Ratio N/A 12.94 N/A
Gross Profit Margin (TTM) N/A 82.52% N/A
Revenue per Share (TTM) $0 $73 Eli Lilly and Company
Earnings per Share (Diluted) $-2.54 $22.94 Eli Lilly and Company
Beta (Stock Volatility) N/A 0.50 N/A
Short % of Float N/A 0.97% N/A

Medicus Pharma Ltd. vs Eli Lilly and Company Stock Performance Analysis

Loading Price Chart...

MDPLD
LLY

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medicus Pharma Ltd.1.78%0.00%0.00%0.00%0.00%0.00%
Eli Lilly and Company-0.32%-1.72%12.38%14.18%6.32%4.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medicus Pharma Ltd.N/AN/AN/AN/AN/AN/A
Eli Lilly and Company38.28%153.07%418.42%1,433.98%2,935.09%1,988.48%

Performance & Financial Health Analysis: Medicus Pharma Ltd. vs Eli Lilly and Company

MetricMDPLDLLY
Market Information
Market Cap iN/A$821.31B
Market Cap CategoryN/AMega cap
10 Day Avg. Volume i20,0912,387,476
90 Day Avg. Volume i36,7122,777,749
Last Close$2.86$1,129.35
52 Week Range$1.80 - $6.00$623.78 - $1,182.73
% from 52W High-52.33%-4.51%
All-Time High$3.00 (Jan 24, 2025)$1,182.73 (Jun 08, 2026)
% from All-Time High-4.67%-4.51%
Growth Metrics
Quarterly Revenue GrowthN/A0.43%
Quarterly Earnings GrowthN/A0.51%
Financial Health
Profit Margin (TTM) i0.00%0.32%
Operating Margin (TTM) i0.00%0.45%
Return on Equity (TTM) i-8.42%1.01%
Debt to Equity (MRQ) i0.10165.31
Cash & Liquidity
Book Value per Share (MRQ)$0.73$29.66
Cash per Share (MRQ)N/A$8.14
Operating Cash Flow (TTM) i$-4,987,008$16.81B
Levered Free Cash Flow (TTM) i$-6,784,140$1.95B
Dividends
Last 12-Month Dividend Yield iN/A0.60%
Last 12-Month Dividend iN/A$6.23

Valuation & Enterprise Metrics Analysis: Medicus Pharma Ltd. vs Eli Lilly and Company

MetricMDPLD (Mar 31, 2025)LLY (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-1.4740.09
Forward P/E iN/A21.82
PEG Ratio iN/A0.79
Price to Sales (TTM) iN/A12.63
Price to Book (MRQ) i3.9031.01
Market Capitalization
Market Capitalization i$22.45M$821.31B
Enterprise Value i$0$843.37B
Enterprise Value Metrics
Enterprise to Revenue iN/A12.94
Enterprise to EBITDA i0.0026.61
Risk & Other Metrics
Beta iN/A0.50
Book Value per Share (MRQ) i$0.73$29.66

Financial Statements Comparison: Medicus Pharma Ltd. vs Eli Lilly and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMDPLD (2023)LLY (2025)
Revenue/Sales i065.18B
Cost of Goods Sold iN/A11.05B
COGS % of Revenue i-17.0%
Gross Profit iN/A54.13B
Gross Margin i-83.0%
Research & Development i193,57813.34B
Operating Income (EBIT) i-3.01M29.70B
Operating Margin i-45.6%
EBITDA i-6.72M35.09B
EBITDA Margin i-53.8%
Pre-Tax Income i-6.78M25.73B
Pre-Tax Income % of Revenue i-39.5%
Income Tax iN/A5.09B
Income Tax % of Revenue i-7.8%
Net Income (Profit) i-6.78M20.64B
Profit Margin i-31.7%

Balance Sheet & Liquidity Metrics

MetricMDPLD (2023)LLY (2025)
Cash & Equivalents i1.72M7.27B
Total Current Assets i1.89M55.63B
Total Current Assets % of Revenue i-85.3%
Total Current Liabilities i1.09M35.23B
Total Current Liabilities % of Revenue i-54.0%
Long-Term Debt iN/A40.87B
Long-Term Debt % of Revenue i-62.7%
Total Shareholders Equity i805,80026.54B
Retained Earnings i-19.18M24.47B
Retained Earnings % of Revenue i-37.5%
Property, Plant & Equipment iN/A13.49B

Cash Flow Statement Comparison

MetricMDPLD (2023)LLY (2025)
Operating Cash Flow i-4.99M23.60B
Operating Cash Flow % of Revenue i-36.2%
Capital Expenditures iN/A-7.84B
Free Cash Flow i-4.16M5.96B
FCF Margin i-9.2%
Debt Repayment iN/A-778.00M
Common Stock Repurchase iN/A-4.11B

Short Interest & Institutional Ownership Analysis

MetricMDPLDLLY
Shares Short iN/A7.70M
Short Ratio iN/A2.73
Short % of Float iN/A0.97%
Shares Outstanding i8.08M894.80M
Float Shares iN/A890.99M
% Held by Insiders i55.81%0.17%
% Held by Institutions i0.00%84.77%
% Held by Public i44.19%15.06%

Dividend Analysis & Yield Comparison: Medicus Pharma Ltd. vs Eli Lilly and Company

MetricMDPLDLLY
Last 12-Month Dividend iN/A$6.23
Last 12-Month Dividend Yield iN/A0.60%
3-Year Avg Annual Dividend iN/A$5.44
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$16.32
Ex-Dividend DateN/AFeb 13, 2026